Skip to main content
CREO MEDICAL GROUP PLC logo

CREO MEDICAL GROUP PLC — Investor Relations & Filings

Ticker · CREO ISIN · GB00BZ1BLL44 LEI · 213800H188ZDCWWXFA21 IL Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-05-15 Earnings Release
Country GB United Kingdom
Listing IL CREO

About CREO MEDICAL GROUP PLC

https://www.creomedical.com/

Creo Medical Group PLC is a medical device company specializing in the development and commercialization of minimally invasive electrosurgical devices for therapeutic endoscopy. The company's core technology platform integrates advanced bipolar radiofrequency for precise tissue cutting with high-frequency microwave energy for controlled coagulation. Its principal products, such as the Speedboat device, are designed to enable clinicians to perform complex procedures like endoscopic submucosal dissection (SSD) to remove gastrointestinal lesions. By providing alternatives to traditional surgery, Creo Medical aims to improve patient outcomes, reduce recovery times, and lower healthcare costs. The company also provides extensive clinical education and training programs to support healthcare professionals in adopting its advanced energy technologies.

Recent filings

Filing Released Lang Actions
Final Results
Earnings Release Classification · 1% confidence The document is titled 'Final Results' for Creo Medical Group PLC for the 12 months ended 31 December 2023. It contains detailed financial highlights (revenue, gross margin, operating loss), operational highlights, and a CEO review. This is a standard earnings release document that provides the initial announcement of annual financial results, fitting the definition of an Earnings Release (ER). FY 2023
2024-05-15 English
Directorate Changes
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number : 0676O) on May 13, 2024, detailing changes to the Board of Directors, specifically the succession of the Chair and the appointment of two new Non-Executive Directors. This content directly matches the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the core subject matter is management change, making MANG the most specific and appropriate classification over the general 'RNS' fallback.
2024-05-13 English
Creo Medical receives King’s Award for Enterprise
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 3363N' and contains a date (07 May 2024). The content announces that Creo Medical Group plc is receiving a 'King's Award for Enterprise in Innovation'. This is a general corporate announcement regarding an award, not a mandatory financial filing like a 10-K, an earnings release (ER), or a specific regulatory report (AR, IR). Since it is a general, non-financial regulatory announcement distributed via RNS, and it doesn't fit into the more specific categories like DIRS, DIV, or MANG, the most appropriate classification is the general regulatory announcement category, RNS.
2024-05-07 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (4553 characters) released via RNS (RNS Number : 9093L) on April 25, 2024. The core content is the 'Notice of Results,' stating that the company 'will announce its audited full year results for the year ended 31 December 2023 on Wednesday 15 May 2024.' It also mentions an accompanying Investor Presentation. Since this document is an announcement about the future publication of results, and not the results themselves (like a 10-K or ER), it fits the definition of a Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because RPA is more specific for announcing the release of other reports.
2024-04-25 English
NHS Speedboat data demonstrates savings
Environmental & Social Information Classification · 1% confidence The document begins with 'RNS Number : 7686L' and is dated April 24, 2024. It contains an announcement from Creo Medical Group PLC regarding NHS Supply Chain data demonstrating cash savings and operational benefits from their Speedboat SSD procedures. The structure, use of RNS numbering, and the nature of the announcement (a corporate update on operational/financial validation of a product) strongly suggest this is a regulatory news service release. Since it is a general corporate announcement that doesn't fit perfectly into specific categories like ER, IR, or CAP, and it is clearly distributed via the RNS system, the most appropriate classification is Regulatory Filings (RNS). The document length (10,852 chars) is substantial, indicating it is the full announcement, not just a brief notice of publication.
2024-04-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' and the footer mentioning RNS and the London Stock Exchange. The content is a 'TR-1: Standard form for notification of major holdings,' which details an acquisition or disposal of voting rights by a major shareholder (Canaccord Genuity Group Inc.). This type of mandatory disclosure regarding changes in significant share ownership thresholds falls under the category of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a notification of a change in major shareholding, making MRQ the most precise classification over the general RNS fallback.
2024-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.